Selected research
Industry Research
Tuberculosis Vaccines Industry Research Report 2026
Market perspective
The global Tuberculosis Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Tuberculosis Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Tuberculosis Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Tuberculosis Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Tuberculosis Vaccines include Bavarian Nordic, China National Biotec Group, GreenSignal Bio Pharma, IDT Biologics, Japan BCG Lab, Serum Institute of India, Taj Pharmaceuticals, GlaxoSmithKline and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Tuberculosis Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tuberculosis Vaccines Market by Company
Bavarian Nordic
China National Biotec Group
GreenSignal Bio Pharma
IDT Biologics
Japan BCG Lab
Serum Institute of India
Taj Pharmaceuticals
GlaxoSmithKline
Merck
Sanofi
Tuberculosis Vaccines Segment by Type
Immunotherapeutic Vaccines
Booster Vaccines
Others
Tuberculosis Vaccines Segment by Application
Hospitals
Clinics
Others
Tuberculosis Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Tuberculosis Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Tuberculosis Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Tuberculosis Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Immunotherapeutic Vaccines
- Booster Vaccines
- Others
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Bavarian Nordic
- China National Biotec Group
- GreenSignal Bio Pharma
- IDT Biologics
- Japan BCG Lab
- Serum Institute of India
- Taj Pharmaceuticals
- GlaxoSmithKline
- Merck
- Sanofi
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Tuberculosis Vaccines Market Size (2021-2032)
- 2.2.2 Global Tuberculosis Vaccines Sales (2021-2032)
- 2.2.3 Global Tuberculosis Vaccines Market Average Price (2021-2032)
- 2.3 Tuberculosis Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Immunotherapeutic Vaccines
- 2.3.3 Booster Vaccines
- 2.3.4 Others
- 2.4 Tuberculosis Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Tuberculosis Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Tuberculosis Vaccines Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Tuberculosis Vaccines Revenue of Manufacturers (2021-2026)
- 3.4 Global Tuberculosis Vaccines Average Price by Manufacturers (2021-2026)
- 3.5 Global Tuberculosis Vaccines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Tuberculosis Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Tuberculosis Vaccines, Product Type & Application
- 3.8 Global Manufacturers of Tuberculosis Vaccines, Established Date
- 3.9 Global Tuberculosis Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bavarian Nordic
- 4.1.1 Bavarian Nordic Company Information
- 4.1.2 Bavarian Nordic Business Overview
- 4.1.3 Bavarian Nordic Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bavarian Nordic Tuberculosis Vaccines Product Portfolio
- 4.1.5 Bavarian Nordic Recent Developments
- 4.2 China National Biotec Group
- 4.2.1 China National Biotec Group Company Information
- 4.2.2 China National Biotec Group Business Overview
- 4.2.3 China National Biotec Group Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 China National Biotec Group Tuberculosis Vaccines Product Portfolio
- 4.2.5 China National Biotec Group Recent Developments
- 4.3 GreenSignal Bio Pharma
- 4.3.1 GreenSignal Bio Pharma Company Information
- 4.3.2 GreenSignal Bio Pharma Business Overview
- 4.3.3 GreenSignal Bio Pharma Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 GreenSignal Bio Pharma Tuberculosis Vaccines Product Portfolio
- 4.3.5 GreenSignal Bio Pharma Recent Developments
- 4.4 IDT Biologics
- 4.4.1 IDT Biologics Company Information
- 4.4.2 IDT Biologics Business Overview
- 4.4.3 IDT Biologics Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 IDT Biologics Tuberculosis Vaccines Product Portfolio
- 4.4.5 IDT Biologics Recent Developments
- 4.5 Japan BCG Lab
- 4.5.1 Japan BCG Lab Company Information
- 4.5.2 Japan BCG Lab Business Overview
- 4.5.3 Japan BCG Lab Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Japan BCG Lab Tuberculosis Vaccines Product Portfolio
- 4.5.5 Japan BCG Lab Recent Developments
- 4.6 Serum Institute of India
- 4.6.1 Serum Institute of India Company Information
- 4.6.2 Serum Institute of India Business Overview
- 4.6.3 Serum Institute of India Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Serum Institute of India Tuberculosis Vaccines Product Portfolio
- 4.6.5 Serum Institute of India Recent Developments
- 4.7 Taj Pharmaceuticals
- 4.7.1 Taj Pharmaceuticals Company Information
- 4.7.2 Taj Pharmaceuticals Business Overview
- 4.7.3 Taj Pharmaceuticals Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Taj Pharmaceuticals Tuberculosis Vaccines Product Portfolio
- 4.7.5 Taj Pharmaceuticals Recent Developments
- 4.8 GlaxoSmithKline
- 4.8.1 GlaxoSmithKline Company Information
- 4.8.2 GlaxoSmithKline Business Overview
- 4.8.3 GlaxoSmithKline Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 GlaxoSmithKline Tuberculosis Vaccines Product Portfolio
- 4.8.5 GlaxoSmithKline Recent Developments
- 4.9 Merck
- 4.9.1 Merck Company Information
- 4.9.2 Merck Business Overview
- 4.9.3 Merck Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Merck Tuberculosis Vaccines Product Portfolio
- 4.9.5 Merck Recent Developments
- 4.10 Sanofi
- 4.10.1 Sanofi Company Information
- 4.10.2 Sanofi Business Overview
- 4.10.3 Sanofi Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sanofi Tuberculosis Vaccines Product Portfolio
- 4.10.5 Sanofi Recent Developments
5 Global Tuberculosis Vaccines Market Scenario by Region
- 5.1 Global Tuberculosis Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Tuberculosis Vaccines Sales by Region: 2021-2032
- 5.2.1 Global Tuberculosis Vaccines Sales by Region: 2021-2026
- 5.2.2 Global Tuberculosis Vaccines Sales by Region: 2027-2032
- 5.3 Global Tuberculosis Vaccines Revenue by Region: 2021-2032
- 5.3.1 Global Tuberculosis Vaccines Revenue by Region: 2021-2026
- 5.3.2 Global Tuberculosis Vaccines Revenue by Region: 2027-2032
- 5.4 North America Tuberculosis Vaccines Market Facts & Figures by Country
- 5.4.1 North America Tuberculosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Tuberculosis Vaccines Sales by Country (2021-2032)
- 5.4.3 North America Tuberculosis Vaccines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Tuberculosis Vaccines Market Facts & Figures by Country
- 5.5.1 Europe Tuberculosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Tuberculosis Vaccines Sales by Country (2021-2032)
- 5.5.3 Europe Tuberculosis Vaccines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Tuberculosis Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific Tuberculosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Tuberculosis Vaccines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Tuberculosis Vaccines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Tuberculosis Vaccines Market Facts & Figures by Country
- 5.7.1 South America Tuberculosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Tuberculosis Vaccines Sales by Country (2021-2032)
- 5.7.3 South America Tuberculosis Vaccines Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Tuberculosis Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Tuberculosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Tuberculosis Vaccines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Tuberculosis Vaccines Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Tuberculosis Vaccines Sales by Type (2021-2032)
- 6.1.1 Global Tuberculosis Vaccines Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Tuberculosis Vaccines Sales Market Share by Type (2021-2032)
- 6.2 Global Tuberculosis Vaccines Revenue by Type (2021-2032)
- 6.2.1 Global Tuberculosis Vaccines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Tuberculosis Vaccines Revenue Market Share by Type (2021-2032)
- 6.3 Global Tuberculosis Vaccines Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Tuberculosis Vaccines Sales by Application (2021-2032)
- 7.1.1 Global Tuberculosis Vaccines Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Tuberculosis Vaccines Sales Market Share by Application (2021-2032)
- 7.2 Global Tuberculosis Vaccines Revenue by Application (2021-2032)
- 7.2.1 Global Tuberculosis Vaccines Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Tuberculosis Vaccines Revenue Market Share by Application (2021-2032)
- 7.3 Global Tuberculosis Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Tuberculosis Vaccines Value Chain Analysis
- 8.1.1 Tuberculosis Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Tuberculosis Vaccines Production Mode & Process
- 8.2 Tuberculosis Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Tuberculosis Vaccines Distributors
- 8.2.3 Tuberculosis Vaccines Customers
9 Global Tuberculosis Vaccines Analyzing Market Dynamics
- 9.1 Tuberculosis Vaccines Industry Trends
- 9.2 Tuberculosis Vaccines Industry Drivers
- 9.3 Tuberculosis Vaccines Industry Opportunities and Challenges
- 9.4 Tuberculosis Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst